Sign Out
Pregnancy: There are no adequate and well controlled studies in pregnant women. If nimodipine is to be administered during pregnancy, the benefits and the potential risks must therefore be carefully weighted according to the severity of the clinical picture.
Lactation: Nimodipine and its metabolites have been shown to appear in human milk at concentrations of the same order of magnitude as corresponding maternal plasma concentrations. Nursing mothers are advised not to breastfeed their babies when taking the drug.
Fertility: In single cases of in-vitro fertilization calcium antagonists have been associated with reversible biochemical changes in the spermatozoa`s head section that may result in impaired sperm function.
